Tiziana Life Sciences (LSE:TILS)

UK company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TILS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TILS

  • Market Cap£144.010m
  • SymbolLSE:TILS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency

Company Profile

Tiziana Life Sciences PLC is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases, and cancer-related to the liver. Its clinical pipeline includes drug assets for Crohn's Disease, COVID19, Secondary Progressive Multiple Sclerosis, and Hepatocellular Carcinoma. Its development pipeline includes Foralumab, Milciclib, Anti-IL6R, and Others. The company has a single reporting segment, which is the research and development of biotechnological & pharmaceutical products.Tiziana Life Sciences PLC develops novel molecules that impact serious human diseases in oncology and immunology. It is focused on developing next-generation therapeutics and diagnostics for cancers and immune diseases.

Latest TILS news

Currently there for this company. Visit our news hub for other news .

TILS Regulatory news

Currently there for this company. Visit our news hub for other news .